VERU logo

VERUVeru Inc

$3.02
$0.38
(11.18%)
Overnight
Updated: 12:01 AM EDT·Prev Close $3.40
Mkt Cap$54.57M
Vol10.8M
84

Extremely Bullish Sentiment

How do you feel about VERU?

News
all
press releases
This Small-Cap Biotech Just Soared Over 160% — What Is The Novo Nordisk Connection?
Veru will evaluate enobosarm alongside Novo Nordisk’s Wegovy in the Phase 2b PLATEAU trial in older adults with obesity.
Stocktwits
News Placeholder
More News
News Placeholder
Earnings call transcript: Veru Inc Q2 2026 shows improved financials
Press Releases
News Placeholder
Veru (VERU) Q1 2026 Earnings Call Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets
News Placeholder
A Look Ahead: Veru's Earnings Forecast
read more...
Benzinga
News Placeholder
Top Wall Street Forecasters Revamp Veru Expectations Ahead Of Q4 Earnings
read more...
Benzinga
News Placeholder
Veru Announces Novel Modified-Release Oral Formulation for Enobosarm
VERU unveils a novel modified-release oral enobosarm to enhance fat loss while preserving lean mass in chronic weight loss management.
Zacks
<
...
1
>

Advertisement|Remove ads.